Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2B | Q13224 | 9/20 | 0.59 |
| ▸ | GRIN1 | Q05586 | 5/20 | 0.59 |
| ▸ | NOS2 | P35228 | 1/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.57 |
| ▸ | G6PC1 | P35575 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.44 |
| ▸ | GRIN3B | O60391 | 2/20 | 0.44 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.44 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.44 |
| ▸ | GRIN3A | Q8TCU5 | 2/20 | 0.44 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2206812 | 1.00 | GRIN2B (0.59) | GRIN2BGRIN1NOS2CYP1A2CYP2D6 | |
| SCHEMBL164345 | 1.00 | GRIN2B (0.59) | GRIN2BGRIN1NOS2CYP1A2CYP2D6 | |
| SCHEMBL27780170 | 0.87 | MEN1 (0.51) | GRIN2BGRIN1NOS2CYP1A2CYP2D6 | |
| SCHEMBL27780177 | 0.87 | NOS2 (0.50) | GRIN2BGRIN1NOS2CYP1A2CYP2D6 | |
| SCHEMBL27780168 | 0.87 | GRIN2B (0.65) | GRIN2BGRIN1NOS2CYP1A2CYP2D6 | |
| SCHEMBL27780339 | 0.85 | NOS2 (0.53) | GRIN2BGRIN1NOS2CYP1A2CYP2D6 | |
| SCHEMBL26231961 | 0.84 | LMNA (0.53) | GRIN2BGRIN1NOS2CYP1A2CYP2D6 | |
| SCHEMBL22328727 | 0.84 | GRIN2B (0.46) | GRIN2BGRIN1NOS2CYP1A2CYP2D6 | |
| SCHEMBL15947206 | 0.84 | NPC1 (0.51) | GRIN2BNOS2HTTL3MBTL1NPC1 | |
| SCHEMBL5799220 | 0.84 | NPC1 (0.51) | GRIN2BNOS2HTTL3MBTL1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8415488-B2 | Bidentate secondary phosphine oxide chiral ligands for use in asymmetric addition reactions | SOLVIAS AG (CH) | 2013-04-09 | — | — | US | claimed |
| US-20110098485-A1 | BIDENTATE SECONDARY PHOSPHINE OXIDE CHIRAL LIGANDS FOR USE IN ASYMMETRIC ADDITION REACTIONS | SOLVIAS AG (CH) | 2011-04-28 | — | — | US | claimed |
| JP-2011503220-A | — | — | 2011-01-27 | — | — | JP | claimed |
| EP-2212340-A1 | BIDENTATE SECONDARY PHOSPHINE OXIDE CHIRAL LIGANDS FOR USE IN ASYMMETRIC ADDITION REACTIONS | Solvias AG (CH) | 2010-08-04 | — | — | EP | claimed |
| WO-2009065783-A1 | BIDENTATE SECONDARY PHOSPHINE OXIDE CHIRAL LIGANDS FOR USE IN ASYMMETRIC ADDITION REACTIONS | SOLVIAS AG (CH) | 2009-05-28 | — | — | WO | claimed |
| JP-11335334-A | — | — | None | — | — | JP | disclosed |
| WO-2019058290-A1 | IMPROVED PROCESS FOR THE PREPARATION OF OZANIMOD Α-AMINO COMPOUND | SUVEN LIFE SCIENCES LIMITED (IN) | 2019-03-28 | — | — | WO | disclosed |
| US-9328079-B2 | Process for producing optically active amine | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2016-05-03 | — | — | US | disclosed |
| US-20150210657-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE AMINE | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2015-07-30 | — | — | US | disclosed |
| US-20140228579-A1 | METHOD FOR THE CATALYTIC REDUCTION OF ACID CHLORIDES AND IMIDOYL CHLORIDES | Brock Unviersity (CA) | 2014-08-14 | — | — | US | disclosed |
| EP-2275427-B1 | Ruthenium-diamine complex and methods for producing optically active compounds | TAKASAGO PERFUMERY CO LTD (JP) | 2013-09-11 | — | — | EP | disclosed |
| EP-2623509-A1 | Method of producing an optically active amine compound by catalytic asymmetric hydrogenation using a ruthenium-diphosphine complex | Kanto Kagaku Kabushiki Kaisha (JP) | 2013-08-07 | — | — | EP | disclosed |
| WO-2002008169-A1 | RUTHENIUM COMPLEXES AND THEIR USE IN ASYMMETRIC HYDROGENATION | CHIROTECH TECHNOLOGY LIMITED (GB) | 2002-01-31 | — | — | WO | disclosed |
| US-6291716-B1 | INTRODUCING ALKYL MOIETY TO AN ORTHO-POSITION OF THE AROMATIC KETONE IN PRESENCE OF A PRIMARY AMINE AND TRANSITION METAL CATALYST, ALKYL MOIETY COMPOUND BEING SOURCED FROM ALIPHATIC OR AROMATIC OLEFINS, INTERNAL OLEFINS OR DIENES | Jun, Chul Ho (KR) | 2001-09-18 | — | — | US | disclosed |
| US-6222072-B1 | RACTING IMINE WITH HYDRIDE REAGENT IN PRESENCE OF OPTICALLY ACTIVE METAL COMPOUND, WHEREIN HYDRIDE REAGENT IS A METAL HYDRIDE, REAGENT THAT UNDERGOES METAL EXCHANGE, METAL TRIALKOXY HYDRIDE COMPLEX OR METAL(TRICARBOXYLIC ACID)HYDRIDE | MITSUI CHEMICALS INC. (JP) | 2001-04-24 | — | — | US | disclosed |
| EP-1086941-A1 | PROCESS FOR PREPARING REDUCTANTS OF UNSATURATED ORGANIC COMPOUNDS BY THE USE OF TRICHLOROSILANE AND REDUCING AGENTS | TOKUYAMA CORPORATION (JP) | 2001-03-28 | — | — | EP | disclosed |
| EP-0901996-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE AMINES | Mitsui Chemicals, Inc. (JP) | 1999-03-17 | — | — | EP | disclosed |
| EP-0691949-B1 | PROCESS FOR THE HYDROGENATION OF IMINES | CIBA GEIGY AG (CH) | 1998-10-14 | — | — | EP | disclosed |
| EP-0691949-A1 | PROCESS FOR THE HYDROGENATION OF IMINES | Novartis AG (CH) | 1996-01-17 | — | — | EP | disclosed |
| WO-1995021151-A1 | PROCESS FOR THE HYDROGENATION OF IMINES | CIBA-GEIGY AG (CH) | 1995-08-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110098485-A1 | BIDENTATE SECONDARY PHOSPHINE OXIDE CHIRAL LIGANDS FOR USE IN ASYMMETRIC ADDITION REACTIONS | H1-2, PHOSPHO1, H1-0 | GRIN2B 1397/4885GRIN1 352/4885NOS2 3184/4885 |
| US-20150210657-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE AMINE | HRH3, HRH1, ATIC | GRIN2B 2614/4885GRIN1 2157/4885NOS2 205/4885 |
| US-20140228579-A1 | METHOD FOR THE CATALYTIC REDUCTION OF ACID CHLORIDES AND IMIDOYL CHLORIDES | CA6, RUVBL2, HACL2 | GRIN2B 1330/4885GRIN1 1346/4885NOS2 1337/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.